Consensus Biodexa Pharmaceuticals Plc

Equities

BDRX

US59564R7089

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-17 pm EDT			5-day change	1st Jan Change
1.19 ^USD	-4.03%		+28.66%	-55.60%

May. 17	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Friday Trading	MT
May. 16	European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	MT

Evolution of the average Target Price on Biodexa Pharmaceuticals Plc

Price target over the last 5 years

History of analyst recommendation changes

c21d6b621d8e658027a7948c0d25d49.HuI8dhg9NG5FtNiZ0YtHXvnh0jjBds1a7ZFv0_8uQT0.SqoRBi0KYRkx_oHUtb8jN7us4w6sNbo43M4lnKp8IFNRi1E0f1VQGSL1kQ~9ebb1183c7998dc59a1294972bf94746

Analyst Recommendations on Biodexa Pharmaceuticals Plc

Ladenburg Thalmann Starts Biodexa Pharmaceuticals With Buy Rating, $8 Price Target

Feb. 08

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.9366 GBP

Average target price

6.337 GBP

Spread / Average Target

+576.62%

High Price Target

6.337 GBP

Spread / Highest target

+576.62%

Low Price Target

6.337 GBP

Spread / Lowest Target

+576.62%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Biodexa Pharmaceuticals Plc

Ladenburg Thalmann

Quarterly revenue - Rate of surprise

Company calendar